tradingkey.logo
搜尋

Eloxx Pharmaceuticals Ord Shs

ELOX
添加自選
13.150USD
+0.260+2.02%
收盤 11-13 16:00(美東)
53.13M總市值
0.00本益比TTM

Eloxx Pharmaceuticals Ord Shs

13.150
+0.260+2.02%

關於 Eloxx Pharmaceuticals Ord Shs 公司

Eloxx Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in the science of ribosome modulation, leveraging both its TURBO- ZM chemistry technology platform and its library of aminoglycosides to develop oral small-molecule ribosome modulating agents (RMAs) and eukaryotic ribosome selective glycosides (ERSGs) for the treatment of rare and ultra-rare genetic diseases. Its lead investigational product candidate, ELX-02, is a small molecule drug candidate designed to restore production of full-length functional proteins. The Company is also advancing ZKN-013 as an oral agent for the treatment of recessive dystrophic (RDEB)/ junctional epidermolysis bullosa (JEB) and familial adenomatous polyposis (FAP) patients with nonsense mutations. The Company also has preclinical programs focused on select rare diseases, including inherited diseases, cancer caused by nonsense mutations, kidney diseases, as well as rare ocular genetic disorders.

Eloxx Pharmaceuticals Ord Shs 簡介

公司代碼- -
公司名稱- -
上市日期- -
CEO- -
員工數量- -
證券類型- -
年結日- -
公司地址- -
城市- -
上市交易所- -
國家- -
郵編- -
電話- -
網址- -
公司代碼- -
上市日期- -
CEO- -

Eloxx Pharmaceuticals Ord Shs公司高管

名稱
名稱/職務
職務
持股
持股變動
Mr. Sumit Aggarwal
Mr. Sumit Aggarwal
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
152.07K
-0.00%
Mr. Sumit Aggarwal
Mr. Sumit Aggarwal
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
152.07K
-0.00%
Mr. Sumit Aggarwal
Mr. Sumit Aggarwal
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
152.07K
-0.00%
Ms. Nina Kjellson
Ms. Nina Kjellson
Independent Director
Independent Director
--
--
Mr. Geno J. Germano
Mr. Geno J. Germano
Independent Director
Independent Director
--
--
Mr. Geno J. Germano
Mr. Geno J. Germano
Independent Director
Independent Director
--
--
Mr. Steven Rubin, J.D.
Mr. Steven Rubin, J.D.
Independent Director
Independent Director
--
--
Mr. Stephen W. Webster
Mr. Stephen W. Webster
Independent Director
Independent Director
--
--
Mr. Steven Rubin, J.D.
Mr. Steven Rubin, J.D.
Independent Director
Independent Director
--
--
Ms. Nina Kjellson
Ms. Nina Kjellson
Independent Director
Independent Director
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Sumit Aggarwal
Mr. Sumit Aggarwal
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
152.07K
-0.00%
Mr. Sumit Aggarwal
Mr. Sumit Aggarwal
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
152.07K
-0.00%
Mr. Sumit Aggarwal
Mr. Sumit Aggarwal
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
152.07K
-0.00%
Ms. Nina Kjellson
Ms. Nina Kjellson
Independent Director
Independent Director
--
--
Mr. Geno J. Germano
Mr. Geno J. Germano
Independent Director
Independent Director
--
--
Mr. Geno J. Germano
Mr. Geno J. Germano
Independent Director
Independent Director
--
--

常見問題

Eloxx Pharmaceuticals Ord Shs的前五大股東是誰?

Eloxx Pharmaceuticals Ord Shs的前五大股東如下:Mr. Sumit Aggarwal
tradingkey.logo
風險提示:我們的網站和行動應用程式僅提供關於某些投資產品的一般資訊。Finsights 不提供財務建議或對任何投資產品的推薦,且提供此類資訊不應被解釋為 Finsights 提供財務建議或推薦。
投資產品存在重大投資風險,包括可能損失投資的本金,且可能並不適合所有人。投資產品的過去表現並不代表其未來表現。
Finsights 可能允許第三方廣告商或關聯公司在我們的網站或行動應用程式的任何部分放置或投放廣告,並可能根據您與廣告的互動情況獲得報酬。
© 版權所有: FINSIGHTS MEDIA PTE. LTD. 版權所有